Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 6-glc-luteolin
2. Homoorientin
3. Iso-orientin
4. Luteolin-6-c-glucoside
1. Homoorientin
2. 4261-42-1
3. Lespecapitioside
4. Luteolin-6-c-glucoside
5. Luteolin 6-c-glucoside
6. 2-(3,4-dihydroxyphenyl)-6-beta-d-glucopyranosyl-5,7-dihydroxy-4h-1-benzopyran-4-one
7. Chebi:17965
8. Luteolin-6-c-beta-d-glucoside
9. A37342tix1
10. Iso-orientin
11. (1s)-1,5-anhydro-1-[2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-4-oxo-4h-chromen-6-yl]-d-glucitol
12. 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-6-((2s,3r,4r,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2h-pyran-2-yl)-4h-chromen-4-one
13. 2-[3,4-bis(oxidanyl)phenyl]-6-[(2s,3r,4r,5s,6r)-6-(hydroxymethyl)-3,4,5-tris(oxidanyl)oxan-2-yl]-5,7-bis(oxidanyl)chromen-4-one
14. 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-6-[(2s,3r,4r,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]chromen-4-one
15. Homoori-entin
16. Unii-a37342tix1
17. 4h-1-benzopyran-4-one, 2-(3,4-dihydroxyphenyl)-6-beta-d-glucopyranosyl-5,7-dihydroxy-
18. Mfcd00017433
19. Lutonaretin
20. Homoorientin; Isoorientin
21. Schembl23761
22. Mls002473101
23. Chembl239559
24. Isoorientin, Analytical Standard
25. Luteolin 6-c-bet.-d-glucoside
26. Isoorientin, >=98% (hplc)
27. Dtxsid50962609
28. 4h-1-benzopyran-4-one, 2-(3,4-dihydroxyphenyl)-6-.beta.-d-glucopyranosyl-5,7-dihydroxy-
29. Luteolin-6-c-b-d-glucopyranoside
30. Hms2225d20
31. Hy-n0767
32. Zinc4349262
33. Isoorientin, >=98.0% (hplc)
34. Bdbm50487756
35. S9248
36. Akos015896766
37. Ccg-208392
38. Cs-7515
39. Ncgc00163566-01
40. Ac-34983
41. As-56302
42. Smr001397203
43. I1087
44. C01821
45. 261h421
46. Q-100474
47. Q3155592
48. Isoorientin, Primary Pharmaceutical Reference Standard
49. 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-6-[(2s,3r,4r,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]chromen-4-one
50. H9r
Molecular Weight | 448.4 g/mol |
---|---|
Molecular Formula | C21H20O11 |
XLogP3 | -0.2 |
Hydrogen Bond Donor Count | 8 |
Hydrogen Bond Acceptor Count | 11 |
Rotatable Bond Count | 3 |
Exact Mass | 448.10056145 g/mol |
Monoisotopic Mass | 448.10056145 g/mol |
Topological Polar Surface Area | 197 Ų |
Heavy Atom Count | 32 |
Formal Charge | 0 |
Complexity | 729 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 5 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?